Characterizing patients with diagnosis of sepsis in an intensive care unit, at Bucaramanga, Colombia 2010-2011

Caracterización de pacientes diagnosticados con sepsis en una unidad de cuidados intensivos de Bucaramanga, Colombia 2010-2011: estudio descriptivo

Published 2016-06-30


https://doi.org/10.30554/archmed.16.1.1538.2016
Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 16 No. 1
Section
Research Articles
How to Cite
Carvajal Estupiñán, J. F., Naranjo Junoy, F., & Ospina Diaz, J. M. (2016). Characterizing patients with diagnosis of sepsis in an intensive care unit, at Bucaramanga, Colombia 2010-2011. Archivos De Medicina (Manizales), 16(1), 53-60. https://doi.org/10.30554/archmed.16.1.1538.2016
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.16.1.1538.2016
Dimensions
PlumX

How to Cite

Carvajal Estupiñán, J. F., Naranjo Junoy, F., & Ospina Diaz, J. M. (2016). Characterizing patients with diagnosis of sepsis in an intensive care unit, at Bucaramanga, Colombia 2010-2011. Archivos De Medicina (Manizales), 16(1), 53-60. https://doi.org/10.30554/archmed.16.1.1538.2016

Download Citation

license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Juan Fernando Carvajal Estupiñán
Francisco Naranjo Junoy
Juan Manuel Ospina Diaz
Perfil Google Scholar
Show authors biography

Juan Fernando Carvajal Estupiñán,

Médico Cirujano, Especialista en Medicina Interna. Grupo de Investigación en Salud Pública.

Francisco Naranjo Junoy,

Médico Cirujano, Especialista en Medicina Interna. Docente Escuela de Medicina Universidad Industrial de Santander.

Juan Manuel Ospina Diaz,

Profesor titular Escuela de Medicina Universidad Pedagógica y tecnológica de Colombia UPTC

Most read articles by the same author(s)

Objective. describe clinical and epidemiological characteristics of patients with infection and diagnosis of sepsis, severe sepsis or septic shock, within an intensive care unit at a Hospital of fourth level of complexity. Sepsis, severe sepsis and septic shock are clinical disorders of increasing incidence in intensive care units; so, it is necessary to assess their characteristics and look for cost-efficient alternatives for the early diagnosis and rational approach. Materials and methods. descriptive, observational Study. Initiating with the design of a standard questioner, were collected and recorded relevant information about patients admitted to the intensive care unit, between June 2010 and May 2011; In total 97 subjects were included. Were evaluated sociodemographic data, comorbidity, length of stay, complications, and alive or death status at the moment of discharge from the intensive care unit. Results. Mean age 49 years, mean length of stay 19 days. overall mortality rate of 39.6% (IC95%: 29,7-50,0%); 68,0% (n=66; IC95%: 58,2-77,8%), was admitted with a diagnosis of infection; in 14.4% (n = 14) of cases the diagnosis of sepsis was made before admission to intensive care unit; in 67.0% (n = 65), in the moment of the admission or up to 24 hours; 18.5% (n = 18), two or more days after admission to the intensive care unit. The most common infections were pneumonia and intraabdominal. The most frequent complications were acute renal failure (59%), respiratory failure (16%) acute lung injury (11%) and multiple organ failure (7%). Conclusions. It is necessary to deepen the design of diagnostic techniques to easy and early identification of sepsis.

Article visits | PDF visits

Downloads

Download data is not yet available.
  1. Pérez MA, Calderón B, Comas B, Tarradas J,
  2. Borges M. Análisis de la concordancia del tratamiento
  3. antibiótico de pacientes con sepsis
  4. grave en urgencias. Rev Esp Quimioter 2015;
  5. (6):295-301
  6. Permpikul C, Srimgam P, Tongyoo S. Therapeutic
  7. goal achievements during severe sepsis and
  8. septic shock resuscitation and their association
  9. with patient’s outcomes. J Med Assoc Thai 2014;
  10. (Suppl 3): S176-183
  11. Jaimes F. A literature review of the epidemiology of
  12. sepsis in Latin America. Rev Panam Salud Publica
  13. ;18(3):163–71.
  14. Pérez IA. Caracterización epidemiológica y microbiológica
  15. de pacientes con sepsis, mayonoviembre
  16. Facultad de Ciencias de la Salud,
  17. Universidad de Carabobo. Ciudad hospitalaria “Dr.
  18. Enrique Tejera” Especialización en Medicina Interna,
  20. Rodríguez F, Barrera L, De La Rosa G, Dennis R,
  21. Dueñas C, Granados M, et al. The epidemiology
  22. of sepsis in Colombia: a prospective multicenter
  23. cohort study in ten university hospitals. Crit Care
  24. Med 2011; 39(7):1675-1682.
  25. Ortiz G, Dueñas C, Rodríguez F, Barrera L, de La
  26. Rosa G, Dennis R, et al. Epidemiology of sepsis in
  27. Colombian intensive care units. Biomédica 2014;
  28. (1):40-47.
  29. González JC, Fonseca JC, González JA. Infección
  30. relacionada con los cuidados sanitarios en la
  31. unidad de cuidados intensivos. Rev Cub Med Int
  32. Emerg 2014; 13(2):143-152.
  33. Martin-Loeches I, Levy MM, Artigas A. Management of
  34. severe sepsis: advances, challenges and current
  35. status. Drug des Devel Ther 2015; 9: 2079-2088.
  36. Mathias B, Szpila BE, Moore FA, Efron PA, Moldawer
  37. LL. A review of GM-CSF therapy in sepsis. Medicine
  38. ; 94(50): e2044.
  39. Vincent JL, Korkut HA. Defining sepsis. Clin Chest
  40. Med 2008; 29(4): 585-590.
  41. Knaus WA, Draper EA, Wagner DP, Zimmerman JE.
  42. Apache II: a severity of disease classification
  43. system. Crit Care Med 1985; 13(10): 818-829
  44. Hernández A, Delgado RI, Castillo JJ, Monteagudo J,
  45. Vinent JA, Monteagudo AR. Pronóstico de mortalidad
  46. con la aplicación de APACHE II en pacientes
  47. graves. Rev Cub Med Int Emerg 2015; 14(3):51-60
  48. García-Simon M, Morales JM, Modesto V, González
  49. V, Vento-Rehues M, Jordá A, et al. Prognosis biomarkers
  50. of severe sepsis and septic shock by H
  51. NMR urine metabolomics in the intensive care
  52. unit. PLoS One 2015; 10(11): e0140993.
  53. Estrada JM, Hincapié JA, Betancur CL. Caracterización
  54. epidemiológica del paciente crítico en
  55. una institución de tercer nivel de atención. Invest
  56. Andina 2005; 7(11):5-15
  57. Velandia JA, Bermúdez EF, Romero PC, Manrique
  58. FG, Ospina JM. Valores de Procalcitonina en pacientes
  59. diagnosticados como sepsis bacteriana
  60. en una Unidad de Cuidado Intensivo. Infectio 2014;
  61. (3): 86-92.
  62. Pierrakos CH, Vincent JL. Biomarkers: a review.
  63. Crit Care 2010; 14:R15.
  64. Vincent JL, Teixeira L. Sepsis biomarkers value
  65. and limitations. Am J Respir Crit Care Med 2014;
  66. :1081–2.
  67. Thompson MR, Rosas G, Lara M, Merino JL, Moreno
  68. HN, Moran E, et al. Diagnóstico molecular de
  69. sepsis polimicrobiana en pacientes internados en
  70. la unidad de cuidados intensivos. Rev Esp Méd
  71. Quir 2014; 19(1):52-61.
  72. Tsertsvadze A, Royle P, McCarthy N. Communityonset
  73. sepsis and it´s public health burden: protocol
  74. of a systematic review. Syst Rev 2015; 4:119
  75. Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo
  76. J, Payen D. Reversal of Neutrophil-to-Lymphocyte
  77. count ratio in early versus late death from septic
  78. shock. Crit Care 2015; 19:439.
  79. Da Almeida D, Lugon JR, Graciano ML. Níveis
  80. séricos de troponina predizem a necessidade de
  81. diálise em pacientes sépticos com injúria renal
  82. aguda renal na unidade de terapia intensiva. J
  83. Bras Nefrol 2015; 37(4): 433-438.

Information

Google Scholar Profile

Author Guidelines